Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
Clinical trial NCT03549338 · TERMINATED
Trial details
- NCT number
- NCT03549338
- Sponsor
- Symphogen A/S
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-29
- Primary completion
- 2019-03-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.